EUVIMEDAtrasti EUVIMED
Open access

Conflicts of Interest Publication Disclosures: Descriptive Study

S Scott Graham, Jade Shiva, Nandini Sharma, Joshua B Barbour, Zoltan P Majdik, Justin F Rousseau

JMIR Data · 2024

DOI: 10.2196/57779 ↗

At a glance

Journal article in JMIR Data, 2024. Written by S Scott Graham and 5 co-authors. Institution: The University of Texas at Austin. 34 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, NLM NIH HHS.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Multiple lines of previous research have documented that author conflicts of interest (COI) can compromise the integrity of the biomedical research enterprise. However, continuing research that would investigate why, how, and in what circumstances COI is most risky is stymied by the difficulty in accessing disclosure statements, which are not widely represented in available databases.

Objective

In this study, we describe a new open access dataset of COI disclosures extracted from published biomedical journal papers.

Methods

To develop the dataset, we used ClinCalc’s Top 300 drugs lists for 2017 and 2018 to identify 319 of the most commonly used drugs. Search strategies for each product were developed using the National Library of Medicine’s and MeSH (Medical Subject Headings) browser and deployed using the eUtilities application programming interface in April 2021. We identified the 150 most relevant papers for each product and extracted COI disclosure statements from PubMed, PubMed Central, or retrieved papers as necessary.

Results

Conflicts of Interest Publication Disclosures (COIPonD) is a new dataset that captures author-reported COI disclosures for biomedical research papers published in a wide range of journals and subspecialties. COIPonD captures author-reported disclosure information (including lack of disclosure) for over 38,000 PubMed-indexed papers published between 1949 and 2022. The collected papers are indexed by discussed drug products with a focus on the 319 most commonly used drugs in the United States.

Conclusions

COIPonD should accelerate research efforts to understand the effects of COI on the biomedical research enterprise. In particular, this dataset should facilitate new studies of COI effects across disciplines and subspecialties.

Subjects

Author keywords

Conflicts of interestbiomedical publishingdatasetresearch integrity

Authors and institutions

  • The University of Texas at Austin.
  • The University of Illinois Urbana-Champaign.
  • North Dakota State University.
  • The University of Texas Southwestern Medical Center.

Funding

  • NIGMS NIH HHS
  • NLM NIH HHS

Cite

APA

Graham, S. S., Shiva, J., Sharma, N., Barbour, J. B., Majdik, Z. P., & Rousseau, J. F. (2024). Conflicts of Interest Publication Disclosures: Descriptive Study. JMIR Data. https://doi.org/10.2196/57779

Vancouver

Graham SS, Shiva J, Sharma N, Barbour JB, Majdik ZP, Rousseau JF. Conflicts of Interest Publication Disclosures: Descriptive Study. JMIR Data. 2024. doi:10.2196/57779

BibTeX
@article{Graham2024,
  author = {Graham, S Scott and Shiva, Jade and Sharma, Nandini and Barbour, Joshua B and Majdik, Zoltan P and Rousseau, Justin F},
  title = {Conflicts of Interest Publication Disclosures: Descriptive Study},
  journal = {JMIR Data},
  year = {2024},
  doi = {10.2196/57779}
}
Start for free →